Bioniche Pharma Gets DDMAC Warning Letter on Sotradecol

Drug Industry Daily
A A
Bioniche Pharma has received a warning letter from the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) for a series of websites intended to promote its varicose vein treatment Sotradecol.

To View This Article:

Login

Subscribe To Drug Industry Daily